Connect Biopharma Holdings Limited

NASDAQ:CNTB

Biotechnology

Healthcare
$0.80 -4.09%

-$0.09 today

Market cap
$50.52M
Beta
-0.21
P/E (TTM)
-4.0
EPS (TTM)
-$0.50
52W Low $0.91High $3.82

Volume 2.50M

Average 0.30M

Income Statement

Follow revenue through to earnings.

Revenue

$64,000.00

FY 2025 · Annual

-99.8% YoY

Operating Income

-$58.07M

FY 2025 · Annual

Net Income

-$55.48M

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00026.03M64K
Cost of Revenue00000
Gross Profit00026.03M64K
Gross Margin———100.0%100.0%
Research & Development80.5M96.63M53M29.26M37.8M
Selling, General & Admin19.01M20.81M16.05M19.23M20.34M
Operating Expenses98.11M119.32M69.06M48.49M58.14M
Depreciation & Amortization634K1.03M720K660K704K
EBITDA(201.36M)(116.74M)(61.27M)(14.75M)(54.58M)
EBITDA Margin———-56.6%-85279.7%
Operating Income(98.11M)(119.32M)(69.06M)(22.45M)(58.07M)
Operating Margin———-86.2%-90740.6%
Interest Income97.67K1.56M5.2K4.45M2.27M
Interest Expense6.91K21.03K000
Other Income / Expenses(103.89M)1.52M7.07M7.05M2.79M
Income Before Tax(202M)(117.79M)(61.99M)(15.41M)(55.28M)
Pre-Tax Margin———-59.2%-86379.7%
Income Tax Expense266K298K120K223K197K
Net Income(202.27M)(118.09M)(62.11M)(15.63M)(55.48M)
Net Margin———-60.0%-86687.5%
EPS (Basic)(25.00)(14.50)(1.08)(0.28)(1.00)
EPS (Diluted)(25.00)(14.50)(1.08)(0.28)(1.00)
Weighted Avg Shares52.27M55.04M55.07M55.21M55.66M
Weighted Avg Shares (Diluted)52.27M55.04M55.07M55.21M55.66M

CNTB Earnings Waterfall · TTM

NASDAQ:CNTB · Revenue to Net Income

Key Ratios

EPS$-0.78
Gross Margin75.0%
Net Margin-7021.8%
P/E Ratio-1.1
P/S Ratio311.4

Analysis

$24.9M of revenue converted into -$22.1M of net income for the selected period. Gross margin is 75.0% and net margin is -7021.8%, showing how much revenue survives after costs and taxes. EPS is $-0.78, tying the income statement back to per-share earnings.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13GSC 13G filingOct 6, 2026
4Statement of changes in beneficial ownershipOct 1, 2026
4Statement of changes in beneficial ownershipOct 1, 2026
8-KCurrent reportSep 30, 2026
8-KCurrent reportSep 15, 2026

How much revenue does CNTB generate?

Connect Biopharma Holdings Limited (CNTB) reported $64,000.00 of revenue in fiscal 2025.

Is CNTB profitable?

Connect Biopharma Holdings Limited (CNTB) reported -$55.48M of net income, with a net margin of -86687.5%.